• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Introduction to tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate (CAS No. 294180-29-3)

tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate, with the CAS number 294180-29-3, is a significant compound in the field of medicinal chemistry and pharmaceutical research. This compound, often referred to as TBMC, is a protected amino acid derivative that plays a crucial role in the synthesis of various bioactive molecules and pharmaceuticals. Its unique structure and properties make it an essential intermediate in the development of drugs targeting neurological disorders, pain management, and other therapeutic areas.

The chemical structure of tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate consists of a tert-butyl carbamate group attached to a trans-4-(methylamino)cyclohexyl moiety. The tert-butyl carbamate group serves as a protecting group for the amino functionality, ensuring its stability during synthetic processes. The trans-4-(methylamino)cyclohexyl moiety, on the other hand, imparts specific conformational and steric properties that are crucial for the compound's biological activity.

In recent years, significant advancements have been made in understanding the biological and pharmacological properties of tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate. Research has shown that this compound exhibits potent activity as an antagonist of the serotonin 5-HT_2C receptor, making it a promising candidate for the treatment of various psychiatric disorders such as depression and anxiety. Additionally, its ability to modulate neurotransmitter systems has led to its exploration in pain management and neurodegenerative diseases.

The synthesis of tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate typically involves several steps, including the formation of the tert-butyl carbamate group and the introduction of the trans-4-(methylamino)cyclohexyl moiety. Various synthetic routes have been reported in the literature, each with its own advantages and limitations. For instance, one common approach involves the reaction of 4-methylaminocyclohexanone with tert-butyl isocyanate, followed by reduction to form the desired product. Another method involves the use of transition metal-catalyzed coupling reactions to achieve high yields and stereoselectivity.

The stability and solubility of tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate are important factors to consider in its application. The compound is generally stable under standard laboratory conditions but may require careful handling to avoid degradation. Its solubility in organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF) makes it suitable for use in various biochemical assays and drug discovery processes.

In preclinical studies, tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate has demonstrated promising results in animal models of depression and anxiety. These studies have shown that the compound can effectively reduce depressive-like behaviors and anxiety symptoms without significant side effects. Furthermore, its ability to cross the blood-brain barrier (BBB) enhances its potential as a therapeutic agent for central nervous system (CNS) disorders.

Clinical trials are currently underway to evaluate the safety and efficacy of tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate in human subjects. Early-phase trials have shown favorable pharmacokinetic profiles and tolerability, paving the way for further investigation in larger patient populations. The ongoing research aims to explore its potential as a novel treatment option for a range of neurological conditions.

Beyond its therapeutic applications, tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate is also used as a research tool in academic and industrial laboratories. Its unique properties make it valuable for studying receptor-ligand interactions, signal transduction pathways, and other fundamental biological processes. Additionally, it serves as a building block for the synthesis of more complex molecules with diverse biological activities.

In conclusion, tert-butyl N-[trans-4-(methylamino)cyclohexyl]carbamate (CAS No. 294180-29-3) is a versatile compound with significant potential in both research and therapeutic applications. Its role as an antagonist of serotonin receptors and its ability to modulate neurotransmitter systems make it an important molecule in the development of new drugs for neurological disorders. As research continues to advance, it is likely that new applications and insights into this compound will emerge, further solidifying its importance in the field of medicinal chemistry.

• 177906-48-8(tert-butyl trans-N-(4-aminocyclohexyl)carbamate)
• 247570-24-7(tert-butyl cis-N-(4-aminocyclohexyl)carbamate)
• 339195-19-6(n-(tert-butoxycarbonyl)aminoferrocene)
• 153789-22-1(tert-butyl N-cyclopentylcarbamate)
• 179412-96-5(tert-butyl N-(5-hydroxypentan-2-yl)carbamate)
• 509143-12-8(tert-butyl N-[cis-4-(2-aminoethyl)cyclohexyl]carbamate)
• 3712-40-1(tert-Butyl N-Cyclohexylcarbamate)
• 347186-01-0(tert-butyl N-(3-aminocyclohexyl)carbamate)
• 195314-59-1(tert-butyl N-(4-aminocyclohexyl)carbamate)
• 167421-84-3(Carbamic acid,[(1R)-1,3-dimethylbutyl]-, 1,1-dimethylethyl ester (9CI))